Clinical Trial Update: Fetal Growth Restriction & Maternal Cardiovascular Risk

View source ↗

Summary

This clinical trial update notes that the study on fetal growth restriction and maternal cardiovascular risk has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Fetal Growth Restriction
• Heart Disease
• Intrauterine Growth Restriction

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED